$2.070
+0.162 (+7.81%)Zum Schluss
HAO im Vergleich zur Peergroup
In the context of the broader market, HAO competes directly with industry leaders such as ONFO and YHC. With a market capitalization of $1.32M, it holds a significant position in the sector. When comparing efficiency, HAO's gross margin of N/A stands against ONFO's 48.88% and YHC's 13.27%. Such benchmarking helps identify whether Haoxi Health Technology Ltd is trading at a premium or discount relative to its financial performance.
Finanzielle Entwicklung von Haoxi Health Technology Ltd
Haoxi Health Technology has shown a declining trend in revenue, with Q2 2026 revenue at 21,000,488 USD, down from 33,828,346 USD in Q1 2026. The gross margin is low at 4.72%, and the company has reported net losses in both quarters of 2026.
Financials
Ähnliche Artikel
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.